Italy’s Dompé Taking Legal Action Over COVID-19 Fake News
Claims circulated on social media that its Cebion supplement could prevent coronavirus has led Italy's Dompé to take legal action.
You may also be interested in...
Reports that ibuprofen could worsen COVID-19 in the early months of the pandemic hit sales of GSK's leading Advil brand, contributing to a drop in pro-forma Consumer Healthcare turnover in the second quarter of 2020.
Countries across Europe are restricting sales of OTC drugs in response to COVID-19 to maintain supply and counteract stockpiling. The approach varies widely across the region: countries such as Germany and France have introduced strict limits, while others, such as the UK and Ireland, have not ordered official restrictions. HBW Insight presents an analysis of the actions taken by 14 European countries to the upsurge in demand for OTCs.
Despite claims last week that ibuprofen worsened the effects of the coronavirus, prices of generic OTC versions of the drug have continued to rise in the UK, reflecting increased demand, according to market analysts Wavedata.